Oncolytics Biotech Inc T.ONC

Relevant update…moving forward

[canadafan]

I do like to read the comparative updates. That being other companies getting deals in huge $$ amounts.
I agree 100% a partnership or buyout, would put Onc SP into multiples of where it is now.
The analysts which can only preject on known business models & ultra conservative, have buy to strong buy ratings.
RBC for example is the lowest @ $6 ps, with an upside of $18ps " on further development news"
Saying that any further news, could easy push the SP well above the $18 ps.
A buyout ? Numbers all over the place. All again multiples of where we are today.
So, what do we know for sure.
1. we are 30 days into the " within 90 day" update of the PanCan phase 3, trial.
2. last year, Q2 results & conference call was Aug 11th. With advisory N.R. July 27th.
That pattern +/- a day or so, consitant many years back.
3. Expect a Q2 update N.R. This week.
4. Looking @ Onc presentation " milestones" There are a few updates expected 2H of this year.
could be anytime between now & end of year.
With 30 of the 90 days gone. Could be up to 60 days.
5. They will be asked & reply @ Q2 CC , the response will be interesting.
listen to what & how they answer.
great week all
stay healthy

[fox7mf]

Indeed, many catalysts are expected 2H of '23 & MC and the BOD are long overdue in creating SH value. Now is the time. Recently a SH here, whose hubris far outweighs his intellect, suggested to me that the BOD owed us nothing. I think most here would disagree. GLTA.

[itntdf]

following is from oncy's press release.  the 90 days (of which we are 30 days removed) was to get the "legal" agreement in place.  see the second paragraph below:  the actual p3 trial is not expected until early 2024.  so, more waiting is the game absent some "real" news. "We are delighted at being selected by the Precision Promise panel of

[Azzak34]

Fingers crossed guys. Remember we chose to invest in this company, we are bystanders to what value they can bring to cancer patients and their families. Some on here have selfish, myopic outlooks and are missing the point. We are invested to make some money but also to see lives saved. Let's not forget that our tinelines and our profit pale in comparison to getting this drug to those who need

[Noteable]

Not really. It's time to sell the company to a big pharma and let them take the drug to those who need it most. Not ONCY.

[fox7mf]

Agreed Noteable. Imagine this investor suggesting that we SH, who have played pivotal roles in keeping the company afloat for all these years aren't owed anything!?! The shortsightedness and ignorance is palpable. This investor has also taken to overusing the word myopic...I think it's just a desperate attempt to counter growing evidence that he or she is just under educated. My opinion

[Azzak34]

Can we get some likes for Fox's comment please? He's been struggling for them recently and I'm worried about his "confidance".  We will be bought out and we will make a lot of money. However my point is that we are not selfless, altruistic benefactors of ONCY here. We're in it to make money so we are subject to the leaders of ONCY running their business as they see

[fox7mf]

Lol, well done Karen...I mean (K)Aaron.

[Azzak34]

Yuck! That's what you went with after reading my post? Man this isn't fun anymore so let's stay out of each other's way. I'm starting to feel bad for you and I don't want to. GLTA. 

[jimsenior]

Who Knew. Goblet cells are intestinal mucosal epithelial cells that serve as the primary site for nutrient digestion and muscosal absorption. They are aslo found among the pancreatic duct cells. When the wraps come off GOBLET, the headlines will say Seminal and Historic. GO

[jimsenior]

To Myself. Correction: mucosal absorption. GO

[Lesalpes29]

Time to put the product in the hands of a BP to accelerate the development for the suffering people. Win win for shareholders and patients. It's the end of the road ONC, ONCY! GL

[fox7mf]

Yup. BP will get this to the cancer sufferers who sorely need more help. That's first and foremost. However, patient shareholders do deserve something for all this time...something big.